EVAg

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the sequence in the segment S region from Oropouche virus and can be used as positive control for extraction and real time RT-PCR using specific Primers and probe ref:001K-06040 . Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

Arb 451 Oropouche virus strain IQT4083, TVP5315. Archival sample whose collection date is unknown. Awaiting sequencing as of 26/08/24. In theory is a cultivable virus but awaiting titre results.

Arb 450 Oropouche virus strain TRVL9760, TVP 14297. Archival sample of which the collection date is unknown. Awaiting whole genome sequencing as of 27/08/24. In theory is a cultivable virus but awaiting titre results.

Arb 449 Oropouche virus panama isolate strain ML 445252, TVP192552. Archival sample of which the collection date is unknown. Awaiting whole genome sequencing as of 27/08/24.

Original strain TRVL9760 was maintained through passage by intracerebral mouse inoculation. Total 9 passages. Inoculated mouse tissue was used to infect Vero cells. Virus stock is P1 on Vero cells.

RNA extracted from infected tissue, Oropouche virus (RIVM/OROV/TRVL9760/09/11/1967).

Hybridoma cell culture supernatant containing anti-Oropouche orthobunyavirus antibodies; targeted antigen: Gc; clone: 2B5B1; immunization antigen: recombinant OROV Gc protein

Hybridoma cell culture supernatant containing anti-Oropouche orthobunyavirus antibodies; targeted antigen: Gc; clone: 8E6A3; immunization antigen: recombinant OROV Gc protein

Hybridoma cell culture supernatant containing anti-Oropouche orthobunyavirus antibodies; targeted antigen: Gc; clone: 8G7A2; immunization antigen: recombinant OROV Gc protein

Pure recombinant Oropouche nucleprotein produced in E. coli and fused with a Hexa-Hisitidine tag.

Oropouche virus, strain IP/OROV/TR9760/12/08/2009